Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Stronger Sell Today AMPH ranks #3319 as SELL CANDIDATE #3319 Weaker Sell

AMPH stock forecast Amphastar Pharmaceuticals

AMPH stock forecast

RANCHO CUCAMONGA, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 8:30 a.m. Eastern Time, New York, NY. This presentation will be made available with a live webcast and may be accessed by visiting Amphastar's Pharmaceuticals website at http://ir.amphastar.com . This webcast will be available for 90 days following the presentation. About Amphastar: Amphastar is a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin active pharmaceutical ingredient products. Most of … Full story available on Benzinga.com

Read more

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2019 Earnings Conference Call May 09, 2019 05:00 PM ET Company Participants Jason Shandell - President, General

Read more

AMPH earnings call for the period ending March 31, 2019.

Read more

Amphastar (AMPH) delivered earnings and revenue surprises of 233.33% and 6.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Read more

Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read more

Tracking some short-term indicators on shares of Amphastar Pharma (AMPH) we note that the current 7-day average directional indicator is Buy. This signal can be used to determine the market trend. The

Read more

Based on the lastest quarterly filings, institutions continue to be large stakeholders in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). The big banks are holding 48.50% of the shares while company in

Read more

In taking a look at some key indicators for CAI International, Inc. (NYSE:CAI), we note that the current Book to Market value for the firm is at 1.391016. The Book to Market or BTM is calculated as Ma

Read more

Stock market investors might be taking note of recent trends. Many investors will be digging deep into the numbers to try and spot potential breakouts. Following the numbers for Amphastar Pharmaceutic

Read more

Many individuals strive to expand their wealth by investing in the stock market. There are countless factors that come in to play when analyzing which stocks to invest in. Along with all the tangible

Read more

Contura Energy, Inc. (NYSE:CTRA) currently has a current ratio of 2.95. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of curren

Read more

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at stocks that have a high earnings yield as well as a

Read more

Superior Plus Corp. (TSX:SPB) has a Value Composite score of 49. Developed by James O’Shaughnessy, the VC score uses six valuation ratios. These ratios are price to earnings, price to cash flow, EBI

Read more

The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Superior Plus Corp. TSX:SPB is 1.838815. A lower price to book ratio in

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank